Estrogen is the main female sex hormone that can be produced both naturally and artificially (premarin). Estrogen replacement for men has been used for hormone-replacement therapy as well as an experimental treatment for prostate cancer.

Estrogen replacement for men is becoming increasingly popular since it was first introduced to the market in 1930. Transsexual women began to take the hormone-replacement therapy drugs hoping to appear more feminine.

Estrogen has also been recently tested as a treatment for men with prostate cancer. Estrogen replacement for men is suspected to stop cancer cells from spreading any further. However, this treatment with estrogen replacement is not yet common.

The side effects of estrogen replacement for men may include:

Hair growth (on the head), vision changes, mood swings, type II diabetes, changes in body temperature, breast-tissue growth, skin irritation and acne, weight gain, enlarged nipples, changes in voice, decreased interest in sex, and a change in body odor.

If estrogen replacement for men is being taken to prevent the spreading of cancer, the benefit of staying healthy may overshadow the side effects your body may experience.

For more information on the side effects of estrogen replacement for men, visit http://www.orderonlinedrugs.com

Asacol, an anti-inflammatory prescription drug, is typically prescribed for treatment of ulcerative colitis. New research suggests that Asacol can also work as drug treatment for inflammatory bowel disease (IBD).

Asacol is an oral enteric-coated pharmaceutical formulation of mesalazine, which can be used as a treatment for inflammatory bowel disease. Asacol has been exclusively licensed since 2004 by Tillotts Pharma AG in Switzerland.

A new agreement has been made that allows clinical trials of treatment for inflammatory bowel disease that will be paid for by Zeria. The trials will include a clinical development for ulcerative colitis treatment and Chrohn’s disease.

After clinical trials are complete, Asacol treatment for inflammatory bowel disease will be available.

For more information on purchasing Asacol treatment for inflammatory bowel disease, visit http://www.orderonlinedrugs.com

A major study has concluded that cure and treatment of a heart attack with Plavix can save lives and reduce the chance of a second heart attack or stroke. The recent clinical trial studied the value of Plavix (clopidogrel) in regards to the cure and treatment of a heart attack patient in cardiac care.

Researchers reported a 50 percent reduction in deaths and other major problems experienced by heart attack patients who received Plavix before, rather than during, artery-opening angioplasty.

Dr. Rory Collins, a professor of medicine and epidemiology at the University of Oxford in England said that “our study shows is that [Plavix] translates into an increase in survival and a reduction of second heart attacks.” These results could change medical practice.

This study of the cure and treatment of a heart attack took place in China and included more than 45,800 patients treated at the start of a heart attack at 1,250 hospitals. Half of these patients were given aspirin, while the rest were treated with Paxil.

The patients who received Paxil for the cure and treatment of a heart attack experienced a 7% lower death rate. In addition, the incidence of a second heart attack during the treatment period was 14% lower and the overall incidence of repeat heart attacks, stoke and death was 9% lower.

For more information on the cure and treatment of a heart attack with Plavix, visit http://www.orderonlinedrugs.com

“Ketamine works as severe depression instant relief by “resetting” the brain”

The National Institute of Mental Health recently conducted research on the Ketamine drug and discovered the possibility of a severe depression instant relief. Participants in the study experienced an antidepressant response to the drug within hours after taking the drug; a response that only occurs days or weeks after taking conventional treatment.

Finding instant relief for severe depression has been a goal of psychiatrics for years; due to the fact that while waiting for relief there can be a high risk of suicide. Ketamine, originally developed in 1962 as a general anesthetic, is more commonly known for its psychedelic effects.

Researchers have explained that Ketamine works as severe depression instant relief by “resetting” the brain. In the studies, it worked as treatment for patients who had already tried different drugs without finding relief.

Surprisingly, Ketamine is already approved by the FDA as “off-label” treatment of addiction and Reflex Sympathetic Dystrophy (chronic pain disorder). Drug companies are now looking for ways to develop this drug as severe depression instant relief treatment without the hallucinatory effects. Research for this treatment is ongoing and patents will likely start arriving from major drug companies.

For more information on severe depression instant relief, visit http://www.orderonlinedrugs.com

“It is imperative that physicians have new and effective treatment options, like Effexor XR, to offer patients”

Panic disorder affects 2.4 million American adults annually and is distinguished by frequent, unexpected panic attacks. These attacks consist of periods of intense fear or discomfort and an accelerated heart rate. It is unknown exactly how Effexor XR works for panic attacks, but new studies are showing that the antidepressant is a viable treatment option.

“Given the complicated, recurrent nature of panic disorder, it is imperative that physicians have new and effective treatment options, like Effexor XR, to offer patients,” said Alexander Bystritsky, M.D., professor of psychiatry at the David Geffen School of Medicine at UCLA and director of the UCLA Anxiety Disorders Program.

The prescription drug was recently approved as treatment for adults with panic disorder. How Effexor XR works for panic attacks was tested in two 12 week placebo-controlled research studies. Patients received doses of 75 or 150 mg/day in the first study, and 75 or 225 mg/day in the second. Researchers found that Effexor XR works for panic attacks more effectively than the placebo for all three dose levels.

Effexor XR works not only for panic attacks, but also for the treatment of adults diagnosed with major depressive disorder such as generalized anxiety disorder (GAD) or social anxiety disorder (SAD).

For more information on how Effexor XR works for panic attacks and depression treatment, visit http://www.orderonlinedrugs.com

“About 50% of all men over the age of 55 will have an enlarged prostate, and by the age of 80 about 90% will suffer from it”.

Impax plans to start shipping the prescription medication as soon as possible for those who cant afford Flomax brand name drugs. The legal settlement ended last October with Astellas Pharma Inc. and Boehringer Ingelheim Pharmaceuticals Inc. over its version of the drug. The settlement allows for Impax to market the generic tamsulosin hydrochloride for patients.

Flomax is used to treat benign prostatic hyperplasia, also known as an enlarged prostate. About 50% of all men over the age of 55 will have an enlarged prostate, and by the age of 80 about 90% will have it. Half of men suffering with the symptoms will require medication or treatment, but many cant afford Flomax due to its expensive cost.

If the cost of Flomax is a concern, it is now possible to switch to the affordable generic alternative. This is something that a patient should speak with a medical professional about, however, as a change may affect people in different ways.

Patients who cant afford Flomax can find more information about the generic option at http://www.orderonlinedrugs.com

“Participants reported that they experienced relief from their symptoms by the morning after the first administration of drug”

New research reports that a new antidepressant TreamW medication, scopolamine, may also produce a fast improvement in mood. Scopolamine works by temporarily blocking the muscarinic cholinergic receptor, which can be overactive in people suffering from depression.

Lead authors of the latest research, Dr. Wayne Drevets and Dr. Maura Furey, studied patients with major depressive disorder who were randomly assigned a placebo and then the scopolamine treatment, or vice versa.

For the antidepressant TreamW test, “Scopolamine was found to reduce symptoms of depression within three days of the first administration. In fact, participants reported that they experienced relief from their symptoms by the morning after the first administration of drug,” said Dr. Furey. “Moreover, one-half of participants experienced full symptom remission by the end of the treatment period. Finally, participants remained well during a subsequent placebo period, indicating that the antidepressant effects persist for at least two weeks in the absence of further treatment.”

Although these findings introduce researchers to a new approach to antidepressant treatment, only time will tell whether fast-acting antidepressant drugs will be effective clinically. However, this possible new treatment shows that a fast-acting antidepressant TreamW treatment can lead to definitive long-term treatment for depression.

For more information about antidepressant prescription drugs, visit http://www.orderonlinedrugs.com

Up to 10% of the population has hand dermatitis, a condition in which the skin on the hand becomes inflamed, normally due to an allergic reaction to an irritant. The hand first becomes dry and chapped before turning red, scaly and inflamed.

During a recent study, more than half of participants who took alitretinoin noticed that their eczema “completely or almost completely” went away after receiving the drug, says Charles Lynde, MD, assistant professor of dermatology at the University of Toronto.

Alitretinoin “does offer new hope for dermatitis we thought was incurable. Patients improve and quite a few go into remission”

Participants in the study consisted of “hard-core patients who weren’t getting better when treated with ointments containing corticosteroids,” which is the standard treatment used to reduce inflammation for patients with severe dermatitis. The success of alitretinoin is especially important due to the fact that “at present, we don’t have very much to offer when corticosteroid [ointments] fail,” says Lynde.

Alitretinoin is similar to the Vitamin A capsule which is approved for severe hand eczema in Europe and Canada, but not in America. To study the effectiveness of the new drug, researchers looked at 1,032 European and Canadian patients who took alitretinoin or a placebo for 12 to 24 weeks.

The participants noticed that their skin condition completely or almost completely resolved itself in 48% of the patients who received high doses of alitretinoin. In comparison, 28% of patients who were given a lower dose and 17% of patients given placebo noticed their skin condition completely or almost completely cleared up.

A second study looked at 249 Europeans and Canadians, all who had suffered from hand eczema for years and who had not responded to normal steroid ointments. Each participant received a high dose of alitretinoin for 24 weeks, and the final results showed that 47% of the patient’s hand rash cleared up.

Finally, researchers studied the patients who had experienced a relapse after their first treatment with alitretinoin (about a third of the patients). They were given alitretinoin for a second time, and 4/5 of the patients had their rash disappear.

While the drug does not work overnight—it typically takes around 4 to 6 weeks—alitretinoin “does offer new hope for dermatitis we thought was incurable. Patients improve and quite a few go into remission,” Lynde says.

For more information about alitretinoin and other prescription drugs to treat eczema, visit http://www.orderonlinedrugs.com



“These are impressive results. Advances in cancer are almost always incremental,”

While a difference of only two to three months may not seem like much, study head Oliver Sartor, MD, a cancer researcher at Tulane Cancer Center in New Orleans, emphasizes the importance of the drug. “These men really don’t have other alternatives,” he said. “They are only expected to live about a year. Cabazitaxel more than doubled the number of men that lived for at least two years.”

The study looked at 755 men in the U.S. whose prostate cancer had continued to spread despite treatment with the chemotherapy drug Taxotere. Around half of the participants were given cabazitaxel intravenously every three weeks.

The study lasted for five years, and those given cabazitaxel were found 30% less likely to die than men not given the drug. Researchers also noticed that men given cabazitaxel remained cancer-free for a longer period of time. The major side effects of the drug included fever accompanied by a decline in white blood cell counts (affecting 7.5% of men), severe nausea (affecting 6%) and severe fatigue (affecting 5%).

As many as 20,000 men in America would benefit from this drug each year, Sartor concluded. Researchers are also planning to test cabazitaxel in men with earlier prostate cancer.

For more information about prescription drugs used to treat and prevent prostate cancer, visit http://www.orderonlinedrugs.com

People who took ibuprofen three or more times a week showed a 40% lower risk for developing the disease than others who did not take the common pain reliever, the study revealed.

These findings are especially important for anyone who is at a serious risk for Parkinson’s disease. Study author Dr. Xiang Gao, an instructor and epidemiologist at Harvard Medical School and Brigham and Women’s Hospital in Boston adds that “there is thus a need for better preventive interventions. In this context, our findings regarding the potential neuroprotective effect of ibuprofen, one of the most commonly used analgesics, on Parkinson’s disease may have important public health and clinical implications.”

Parkinson’s is a disease that takes over the nerve cells in the brain that control muscle movement. In the United States, around 1 million people have been affected by the disease. The exact cause of the disease is still unknown, but scientists believe it may be due to a combination of genetic and environmental factors. Currently, the prescription drug levodopa is issued as the standard treatment for Parkinson’s, but more options are still needed.

Results from Gao’s study came from analyzing data on 136,474 people who did not have Parkinson’s at the beginning of the research. After a six year span, 293 people were diagnosed with the disease. The participants who took the largest doses of ibuprofen were found to be less likely to have developed Parkison’s over those who took smaller amounts of the drug. No other pain reliever was found to decrease the risk for Parkinson’s.

Dr. Michele Tagliati, an associate professor of neurology and director of the Parkinson’s Disease Center at the Mount Sinai School of Medicine in New York City, described the study as “eye-opening” and stressed the need for further study in the area.

Tagliati added that he would now “definitely discuss ibuprofen use” with his patients. This is due to the fact that if helps protect against the disease, it may also benefit those who already have Parkinson’s disease.

Doctors have cautioned that continual use of ibuprofen can lead to gastritis (inflammation of the stomach lining). But Tagliati responds that, in comparison, the effects of gastritis are significantly less than the effects of Parkinson’s which can include loss of balance, stiffness, hallucinations and dementia.

For more information about Ibuprofen, Levodopa prescription drugs and other treatment for Parkinson’s, visit http://www.orderonlinedrugs.com